These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5439606)

  • 1. [The capillary enzyme barrier for DOPA at the level of some brain stem nuclei in the rat].
    Constantinidis J; Bartholini G; Geissbühler F; Tissot R
    Experientia; 1970 Apr; 26(4):381-3. PubMed ID: 5439606
    [No Abstract]   [Full Text] [Related]  

  • 2. Passage into the rat brain of dopa and dopamine injected into the lateral ventricle.
    Constantinidis J; Gaillard JM; Geissbuhler F; Tissot R
    Br J Pharmacol; 1971 Sep; 43(1):32-8. PubMed ID: 5136462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine formation in brain capillaries--an enzymic blood-brain barrier mechanism.
    Owman C; Rosengren E
    J Neurochem; 1967 May; 14(5):547-50. PubMed ID: 6025622
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 5. The occurrence of biogenic monoamines in the mammalian endocrine pancreas.
    Cegrell L
    Acta Physiol Scand Suppl; 1968; 314():1-60. PubMed ID: 4973243
    [No Abstract]   [Full Text] [Related]  

  • 6. A rapid fluorescence microscopic method for the study of the capillary DOPA-dopamine barrier.
    Jancsó G
    J Neurochem; 1975 Mar; 24(3):579-80. PubMed ID: 1113128
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain DOPA-5-HTP decarboxylase activity after the chronic administration of L-dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats.
    Roberge AG; Poirier LJ
    Brain Res; 1974 Aug; 76(3):401-12. PubMed ID: 4546739
    [No Abstract]   [Full Text] [Related]  

  • 8. Degeneration of central and peripheral noradrenaline neurons produced by 6-hydroxy-DOPA.
    Sachs C; Jonsson G
    J Neurochem; 1972 Jun; 19(6):1561-75. PubMed ID: 5035304
    [No Abstract]   [Full Text] [Related]  

  • 9. Relative penetration of L-dopa and 5-HTP through the brain barrier using dimethyl sulfoxide.
    De la Torre JC
    Experientia; 1970 Oct; 26(10):1117-8. PubMed ID: 5312418
    [No Abstract]   [Full Text] [Related]  

  • 10. THE DIRECT DEMONSTRATION OF A BARRIER MECHANISM IN THE BRAIN CAPILLARIES.
    BERTLER A; FALCK B; ROSENGREN E
    Acta Pharmacol Toxicol (Copenh); 1963; 20():317-21. PubMed ID: 14162814
    [No Abstract]   [Full Text] [Related]  

  • 11. Uptake of some catecholamines and their precursors into neurons of the rat ciliary ganglion.
    Ehinger B; Falck B
    Acta Physiol Scand; 1970 Jan; 78(1):132-41. PubMed ID: 4986830
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
    Vetulani J; Reichenberg K
    Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced changes in monoamine levels in the sympathetic adrenergic ganglion cells and terminals. A histochemical study.
    Norberg KA
    Acta Physiol Scand; 1965 Nov; 65(3):221-34. PubMed ID: 4379526
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of chronically administered L-dopa on dopa 5HTP decarboxylase and tyrosine and tryptophan hydroxylases in cat brain.
    Roberge AG; Poirier LJ
    J Neural Transm; 1973; 34(3):171-85. PubMed ID: 4146520
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
    Maj J; Pawlowski L; Sarnek J
    Adv Biochem Psychopharmacol; 1974; 10():253-6. PubMed ID: 4846541
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional role of the nigro-neostriatal dopamine neurons.
    Andén NE; Dahlström A; Fuxe K; Larsson K
    Acta Pharmacol Toxicol (Copenh); 1966; 24(2):263-74. PubMed ID: 5297995
    [No Abstract]   [Full Text] [Related]  

  • 17. Histochemical studies on the distribution of catecholamines and 5-hydroxytryptamine after intraventricular injections.
    Fuxe K; Ungerstedt U
    Histochemie; 1968; 13(1):16-28. PubMed ID: 5741831
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopa-decarboxylase and monoamine oxidase activities in a transplantable islet cell tumor of the golden hamster.
    Cegrell L; Falck B; Rosengren AM
    Experientia; 1969 Sep; 25(9):969-70. PubMed ID: 4313355
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for dopamine autoreceptors controlling dopamine synthesis in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Gessa GL
    Brain Res; 1982 Feb; 234(1):177-81. PubMed ID: 6800566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain.
    Constantinidis J; Bartholini G; Tissot R; Pletscher A
    Experientia; 1968 Feb; 24(2):130-1. PubMed ID: 5643797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.